A detailed history of Pnc Financial Services Group, Inc. transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 200 shares of CRBU stock, worth $306. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$306
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$1.62 - $5.05 $178 - $555
-110 Reduced 35.48%
200 $0
Q4 2023

Feb 09, 2024

BUY
$3.58 - $6.25 $393 - $687
110 Added 55.0%
310 $1,000
Q3 2023

Nov 13, 2023

SELL
$4.08 - $8.14 $408 - $814
-100 Reduced 33.33%
200 $0
Q2 2023

Aug 11, 2023

BUY
$4.04 - $5.47 $808 - $1,094
200 Added 200.0%
300 $1,000
Q3 2021

Nov 05, 2021

BUY
$15.75 - $30.29 $1,575 - $3,029
100 New
100 $2,000

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $93.1M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.